BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Starosta RT, Vairo FPE, Dornelles AD, Basgalupp SP, Siebert M, Pedroso MLA, Cerski CTS, Álvares-da-Silva MR, Schwartz IVD. Liver involvement in patients with Gaucher disease types I and III. Mol Genet Metab Rep 2020;22:100564. [PMID: 32099816 DOI: 10.1016/j.ymgmr.2019.100564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Alnaghy E, Razek AA, Abdelhalim E. Pre- and post-therapeutic evaluation of liver and spleen in type I and type III Gaucher's disease using diffusion tensor imaging. Abdom Radiol (NY) 2022. [PMID: 35867132 DOI: 10.1007/s00261-022-03602-5] [Reference Citation Analysis]
2 Starosta RT, Álvares-da-Silva MR, Schwartz IVD. Concerning 'Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease' by Nascimbeni et al. Liver Int 2021;41:226. [PMID: 32937022 DOI: 10.1111/liv.14668] [Reference Citation Analysis]
3 Starosta RT, Siebert M, Vairo FPE, Costa BLL, Ponzoni CT, Schwartz IVD, Cerski CTS. Histomorphometric analysis of liver biopsies of treated patients with Gaucher disease type 1. Autops Case Rep 2021;11:e2021306. [PMID: 34458174 DOI: 10.4322/acr.2021.306] [Reference Citation Analysis]
4 Serfecz JC, Saadin A, Santiago CP, Zhang Y, Bentzen SM, Vogel SN, Feldman RA. C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages. Int J Mol Sci 2021;22:9912. [PMID: 34576075 DOI: 10.3390/ijms22189912] [Reference Citation Analysis]
5 Cabrera-Reyes F, Parra-Ruiz C, Yuseff MI, Zanlungo S. Alterations in Lysosome Homeostasis in Lipid-Related Disorders: Impact on Metabolic Tissues and Immune Cells. Front Cell Dev Biol 2021;9:790568. [PMID: 34957117 DOI: 10.3389/fcell.2021.790568] [Reference Citation Analysis]